Orum Therapeutics, Inc.

Share · KR7475830006 (XKOS)

Overview

No Price

Closing Price XKOS 27.10.2025: 39.850,00 KRW

27.10.2025 06:30

Current Prices from Orum Therapeutics, Inc.

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
KOSDAQ	475830.KQ	KRW	27.10.2025 06:30	39.850,00 KRW	5.850,00 KRW +17,21 %

Share Float & Liquidity

Free Float 67,67 %

Shares Float 14,26 M

Shares Outstanding 21,07 M

Company Profile for Orum Therapeutics, Inc. Share

Orum Therapeutics, Inc., a biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases. The company focuses on degrader-antibody conjugate that combine antibody-drug conjugate with targeted protein degradation technology. Its lead product candidate is ORM-1153, a GSPT1 protein degrader that targets hematologic malignancies. The company was founded in 2016 and is based in Daejeon, South Korea.

Get up to date insights from finAgent about Orum Therapeutics, Inc.

Company Data

Name Orum Therapeutics, Inc.

Company Orum Therapeutics, Inc.

Website https://www.orumrx.com

Primary Exchange

KOSDAQ

ISIN KR7475830006

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Sung-Joo Lee

Market Capitalization 498 Mrd.

Country South Korea

Currency KRW

Employees 0,0 T

Address 281-25 Munji-ro, 34050 Daejeon

IPO Date 2025-02-14

Ticker Symbols

Name	Symbol
KOSDAQ	475830.KQ

More Shares

Investors who hold Orum Therapeutics, Inc. also have the following shares in their portfolio:

Federated Hermes MDT Large Cap Value Fund Service Shares Fund

NBCUNIVERS.MEDIA 11/41 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog